|
|
||||||||
1From the Departments of Ophthalmology and 2Physiology and Biophysics, Mount Sinai School of Medicine, New York, New York.
PURPOSE. To investigate the expression and localization of urokinase plasminogen activator (uPA) and its receptor (uPAR) and their interaction with the actin cytoskeleton in human corneal fibroblasts.
METHODS. Primary cultured human corneal fibroblasts were exposed to exogenous uPA to investigate its effect on the distribution of uPAR under resting conditions and in a scrape-wound model. Fluorescence microscopy, immunolocalization, immunoprecipitation, and the actin depolymerizing drug cytochalasin D were used to evaluate uPARs interaction with the actin cytoskeleton.
RESULTS. uPA/uPAR was immunodetected in large (200 µm2) aggregates devoid of detectable F-actin. However, when uPA was added to corneal fibroblasts before fixation, a dynamic association between uPAR and the actin cytoskeleton was revealed: the uPA/uPAR complex was immunodetected throughout the surface of the plasma membrane in the form of dispersed small aggregates (0.05 µm2). Association of uPAR with actin stress fibers was visualized when FITC-labeled uPA was added to the cells. This codistribution of uPA/uPAR and actin was not detected when the cells were pretreated with the actin-depolymerizing drug, cytochalasin D. uPAR was found also in focal adhesions, the termination points of F-actin, where it colocalized with the integrin
vß3 in cells migrating into a scrape wound. Coimmunoprecipitation experiments confirmed the physical association of uPAR with
vß3 in fibroblasts.
CONCLUSIONS. The authors propose that uPA/uPAR ligation anchors the complex to the actin cytoskeleton and is a part of the mechanism responsible for uPA-induced cell migration in fibroblasts.
This article has been cited by other articles:
![]() |
A. M. Bernstein, S. S. Twining, D. J. Warejcka, E. Tall, and S. K. Masur Urokinase Receptor Cleavage: A Crucial Step in Fibroblast-to-Myofibroblast Differentiation Mol. Biol. Cell, July 1, 2007; 18(7): 2716 - 2727. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Begin, K. Tremblay, D. Daley, M. Lemire, S. Claveau, C. Salesse, S. Kacel, A. Montpetit, A. Becker, M. Chan-Yeung, et al. Association of Urokinase-type Plasminogen Activator with Asthma and Atopy Am. J. Respir. Crit. Care Med., June 1, 2007; 175(11): 1109 - 1116. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Leonardi, P. Brun, M. T. Sartori, R. Cortivo, C. DeDominicis, G. Saggiorato, G. Abatangelo, and A. G. Secchi Urokinase Plasminogen Activator, uPa Receptor, and Its Inhibitor in Vernal Keratoconjunctivitis Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1364 - 1370. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Taliana, M. Benezra, R. S. Greenberg, S. K. Masur, and A. M. Bernstein ZO-1: Lamellipodial Localization in a Corneal Fibroblast Wound Model Invest. Ophthalmol. Vis. Sci., January 1, 2005; 46(1): 96 - 103. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |